Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Current Deferred Revenue (2020 - 2025)

GoHealth's Current Deferred Revenue history spans 6 years, with the latest figure at $29.2 million for Q3 2025.

  • For Q3 2025, Current Deferred Revenue fell 31.62% year-over-year to $29.2 million; the TTM value through Sep 2025 reached $29.2 million, down 31.62%, while the annual FY2024 figure was $53.7 million, 2.51% up from the prior year.
  • Current Deferred Revenue for Q3 2025 was $29.2 million at GoHealth, down from $33.4 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $114.2 million in Q3 2022 and bottomed at $536000.0 in Q4 2021.
  • The 5-year median for Current Deferred Revenue is $27.8 million (2024), against an average of $29.9 million.
  • The largest annual shift saw Current Deferred Revenue plummeted 98.99% in 2021 before it soared 20253.12% in 2022.
  • A 5-year view of Current Deferred Revenue shows it stood at $536000.0 in 2021, then surged by 9339.18% to $50.6 million in 2022, then increased by 3.58% to $52.4 million in 2023, then grew by 2.51% to $53.7 million in 2024, then tumbled by 45.65% to $29.2 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Current Deferred Revenue are $29.2 million (Q3 2025), $33.4 million (Q2 2025), and $23.7 million (Q1 2025).